Takayuki Watanabe
Chuo, 9518510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice.
Journal: Inflammation and regeneration
Published: June 15, 2021
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis.
Journal: NPJ Regenerative medicine
Published: August 06, 2020
Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH.
Journal: Biochemical and biophysical research communications
Published: July 19, 2020
Screening and follow-up of chronic liver diseases with understanding their etiology in clinics and hospitals.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: June 29, 2020
Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles.
Journal: Regenerative therapy
Published: December 16, 2019
Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model.
Journal: BioResearch open access
Published: November 14, 2019
Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions.
Journal: Regenerative therapy
Published: July 03, 2019
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration.
Journal: Inflammation and regeneration
Published: April 05, 2019
Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma.
Journal: Heliyon
Published: June 18, 2018
A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion.
Journal: The American journal of case reports
Published: September 19, 2017
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient.
Journal: Clinical journal of gastroenterology
Published: January 26, 2017
Last Updated: 09/26/2026